Faculty Awards - Faculty of Health Sciences - McMaster University

134
PUBLICATIONS
bowel syndrome) treatment. Can J Gastroenterol 2007
Apr; 21 Suppl B:3B-22B.
Book Chapter
Ganguli, SC. Drugs,Gastrointestinal Motility and
Inflammatory Bowel Disease. In: Principles of Medical
Pharmacology, H Kalant (ed.) Saunders, 2007. ISBN:
0779699459
GAUVREAU, G.
Publications
Farrell E, O’Connor TM, Duong M, Watson RM, Strinich
T, Gauvreau GM, O’Byrne PM. Circulating myeloid and
plasmacytoid dendritic cells after allergen inhalation in
asthmatic subjects. Allergy 2007; 62:1139-45.
Duong M, Gauvreau G, Watson R, Obminski G, Strinich
T, Evans M, Howie K, Killian K, O’Byrne PM. The effects
of inhaled budesonide and formoterol in combination
and alone when given directly after allergen challenge.
J Allergy Clin Immunol. 2007; 119:322-7.
Boulet LP, Gauvreau G, Boulay ME, O’Byrne P,
Cockcroft DW; Clinical Investigative Collaboration,
Canadian Network of Centers of Excellence AllerGen.
The allergen bronchoprovocation model: an important
tool for the investigation of new asthma anti-inflammatory
therapies. Allergy. 2007; 62:1101-10.
Smith SG, Gauvreau GM. IL-13 is a novel therapeutic
target in allergic asthma. Expert Rev Clin Immunol
2007; 3:671-675.
Book Chapter
Gauvreau GM, Evans MY. Allergen Inhalation
Challenge – A Human Model of Asthma Exacerbation..
In: Models of Exacerbations in Asthma and COPD, Eds:
U Sjöbring, JD Taylor. Karger AG, Basel, Switzerland,
2007.
GERSTEIN, H.
Publications
Suskin NG, Heigenhauser G, Afzal R, Finegood D,
Gerstein HC, McKelvie RS. The effects of exercise training
on insulin resistance in patients with coronary
artery disease. Eur J Cardiovasc Prev Rehabil 2007;
14(6):803-8.
Holloway AC, Cuu DQ, Morrison KM, Gerstein HC,
Tarnopolsky MA. Transgenerational effects of fetal
and neonatal exposure to nicotine. Endocrine 2007;
31(3):254-259.
Houlden R, Ross S, Harris S, Yale JF, Sauriol L, Gerstein
HC. Treatment satisfaction and quality of life using
an early insulinization strategy with insulin glargine
compared to an adjusted oral therapy in the management
of Type 2 diabetes: The Canadian INSIGHT Study.
Diabetes Res Clin Pract 2007; 78:254-258.
Punthakee Z, Werstuck G, Gerstein HC. Diabetes and
Cardiovascular Disease: Explaining the Relationship.
Rev Cardiovasc Med 2007; 8(3):145-53.
Voruganti LP, Punthakee Z, VanLieshout R, acCrimmon
D, Parker G, Gerstein HC. Prevalence of dysglycemia
in a schizophrenic population. Schizophrenia Research
2007; 96(1-3):215-22.
Gerstein HC, Santaguida P, Raina P, Morrison KM,
Balion C, Hunt D, Yazdi H, Booker L. Annual incidence
and relative risk of diabetes in people with various
categories of dysglycemia: A systematic overview and
meta-analysis of prospective studies. Diabetes Res Clin
Pract 2007; 78(3):305-12.
Balion CM, Raina P, Gerstein HC, Santaguida P,
Morrison KM, Booker L, Hunt F. Review: Reproducibility
of impaired glucose tolerance (IGT) and impaired fasting
glucose (IFG) classification: a systematic review.
Clin Chem Lab Med 2007; 45:1180-1185.
Nair KM, Levine MAH, Lohfeld LH, Gerstein HC. “I
take what I think works for me”: a qualitative study
to explore patient perception of diabetes treatment
benefits and risks. Canadian Journal of Clinical
Pharmacology 2007; 14(2):e251-9.
Held C, Gerstein HC, Yusuf S, Zhao F, Hilbrich L,
Anderson C, Sleight P, Teo K, ONTARGET/TRANSCEND
Investigators. Glucose levels predict hospitalization for
congestive heart failure in patients at high cardiovascular
risk. Circulation 2007; 115(11):1371-5.
Gerstein HC, Riddle MC, Kendall DM, Cohen RM,
Goland R, Feinglos MN, Kirk JK, Hamilton BP, Ismail-
Beigi F, Feeney P. Glycemia treatment strategies in
the Action to Control Cardiovascular Risk in Diabetes
(ACCORD) Trial. Am J Cardiol 2007; 99(suppl):34i-43i.
Goff DC, Gerstein HC, Ginsberg HN, Cushman
WC, Margolis KL, Byington RP, Buse J, Genuth S,
Probstfield JL, Simons-Morton DG. Prevention of cardiovascular
disease in persons with type 2 Diabetes
Mellitus: Current knowledge and rationale for the
Action to Control Cardiovascular Risk in Diabetes
(ACCORD) Trial. Am J Cardiol 2007; 99(suppl):4i-20i.
Bruin JE, Kellenberger LD, Gerstein HC, Morrison KM,
Holloway AC. Fetal and Neonatal Nicotine Exposure
and Postnatal Glucose Homeostasis: Identifying Critical
Windows of Exposure. J Endocrinol 2007; 194:171-178.
Becker T, Moldoveanu A, Cukierman T, Gerstein HC. The
Risk of Using Subcutaneous Insulin-by-Glucose Sliding
Scales to Manage Hyperglycemia in Hospitalized
Patients with Pneumonia. Diab Res Clin Pract 2007;
78(3):392-7.
Sawka AM, Boulos P, Talib AS, Gafni A, Thabane L,
Papaioannou A, Booth G, Gerstein HC. Is low socioeconomic
status associated with an increased risk of
severe hypoglycemia in Type 1 diabetes? A systematic
review of the literature. Can J Diabetes 2007; 31:233-
241.
Houlden R, Ross S, Harris S, Yale J-F, Sauriol S,
Gerstein HC, Treatment Satisfaction and Quality of
Life using an Early Insulinization Strategy with Insulin
Glargine Compared to an Adjusted Oral Therapy in
the Management of Type 2 Diabetes: The Canadian
INSIGHT Study. Diab Res Clin Prac 2007; 78(2):254-8.
Gangji AS, Cukierman T, Gerstein HC, Goldsmith C,
Clase CM. A Systematic Review and Meta-analysis
of Hypoglycemia and Cardiovascular Events: A
Comparison of Glyburide with Other Secretagogues
and with Insulin. Diabetes Care 2007; 30:389-394.
Buse J, Ginsberg H, Bakris G, Clark NG, Costa F, Eckel
R, Fonseca F, Gerstein HC, Grundy S, Nesto RW,
Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel
KF, Stone NJ. Primary prevention of cardiovascular
disease in people with diabetes: A joint statement
and recommendations from the American Diabetes
Association and the American Heart Association.
Diabetes Care 2007; (1):162-72 and Circulation 2006.
GINSBERG, J.
Publications
Laine L, Curtis SP, Cryer B, Kaur A, Cannon CP, for the
MEDAL Steering Committee. Assessment of upper
gastrointestinal safety of etoricoxib and diclofenac in
patients with osteoarthritis and rheumatoid arthritis in
the Multinational Etoricoxib and Diclofenac Arthritis
Long-term (MEDAL) programme: a randomized comparison.
Lancet 2007; 369:465-473.
Agnelli G, Haas S, Ginsberg JS, Krueger KA,
Dmitrienko A, Brandt JT. A study of the oral factor Xa
inhibitor LY517717 for the prevention of venous thromboembolism
after hip or knee replacement. J Thromb
Haemost 2007; 5:1-8.
Craven SJ, Dewar L, Yang X, Ginsberg J, Kassis J,
Ofosu FA. Altered regulation of in vivo coagulation in
orthopedic patients prior to knee or hip replacement
surgery. Blood Coagul Fibrinolysis 2007; 18:219-225.
Lim W, Eikelboom JW, Ginsberg JS. Pregnancy Plus:
Inherited thrombophilia in pregnancy-associated
venous thromboembolism. Br Med J 2007; 334:1318-
1321.
Kahn SR, Shbaklo H, Wells PS, Kovacs MJ, Rodger
M, Anderson DR, Ginsberg JS, Johri M, Tagalakis
V, Shapiro S, for the SOX Trial Investigators.
Effectiveness of compression stockings to prevent the
post-thrombotic syndrome (The SOX Trial and Bio-SOX
biomarker substudy): A randomized controlled trial.
BMC Cardiovasc Dis 2007; 7:21.
Chan WS, Chunilal S, Lee A, Crowther M, Rodger M,
Ginsberg JS. A red blood cell agglutination D-dimer
test for the diagnosis of DVT in pregnancy: A prospective
cohort study. Ann Intern Med 2007; 147:165-170.
Book Chapters
Tran HAM, Ginsberg JS. Anticoagulant therapy in pregnancy.
In: Greer, Ginsberg, Forbes, editors. Women’s
Vascular Health. London: Hodder Arnold Health
Sciences, pp 148-160, 2007.
McRae SJ, Ginsberg JS. Treatment of venous thrombosis
in pregnancy. In: Greer, Ginsberg, Forbes, editors.
Women’s Vascular Health. London: Hodder Arnold
Health Sciences, pp. 292-316, 2007.
Book
Women’s Vascular Health. Eds: Greer IA, Ginsberg JS,
Forbes CD. Hodder Arnold (Health Sciences), Glasgow
UK 2007.
GULENCHYN, K.
Publications
Marriott CJ, Webber CE, Gulenchyn KY. Radiation
Exposure for ‘Caregivers’ During High-Dose Outpatient
Radioiodine Therapy, Radiation Protection Dosimetry
2007; 123(1):62-67.
Beanlands RS, Chow BJ, Dick A, Friedrich MG,
Gulenchyn KY, Kiess M, Leong-Poi H, Miller RM, Nichol
G, Freeman M, Bogaty P, Honos G, Wisenberg G, Van
Berkom J, Williams K, Yoshinga K, Graham J. CCS/
CAR/CANM/CNCS/CanSCMR Joint Position Statement
on Advanced Cardiac Imaging using Positron Emission
Tomography, Magnetic Resonance Imaging and
Multidetector computed Tomographic Angiography
in the Diagnosis and Evaluation of Ischemic Heart
Disease – Executive Summary, Can J Cardiol 2007;
23(2):107-19.
Ung YC, Maziak DE, Vanderveen JA, Smith CA,
Gulenchyn K, Evans WK. 18-Fluorodeoxyglucose
Positron Emission Tomography in the Diagnosis and
Staging of Lung Cancer: A Systematic Review, J Natl
Cancer Inst 2007; 99:1753-67.
Beanlands RSB, Nichol G, Huszti E, Humen D, Racine
N, Freeman M, Gulenchyn KY, Garrard L, deKemp R,
Guo A, Ruddy TD, Benard F, Lamy A, Iwanochko RM,
and the PARR-2 Investigators. F-18-Fluorodeoxyglucose
Positron Emission Tomography Imaging-Assisted
Management of Patients with Severe Left Ventricular
Dysfunction and Suspected Coronary Artery Disease. J
Am Coll Cardiol 2007; 50(20):2002-12.
GUPTA, M.
Publications
Banerjee AT, Gupta M, Singh N. Patient
Characteristics, Compliance, and Exercise Outcomes
of South Asians Enrolled in Cardiac Rehabilitation. J
Cardiopulm Rehabil Prev 2007; 27(4):212-18.
Deedwania PC, Gupta M, Stein M, Ycas J, Gold A; IRIS
Study Group. Comparison of rosuvastatin versus
atorvastatin in South-Asian patients at risk of coronary
heart disease (from the IRIS Trial). Am J Cardiol 2007;
99(11):1538-43.
Gupta M, Verma S, Mancini GB. ACE-Inhibitors: Back to
Prime Time? Heart. 2007; 3(9):1015-6.
GUYATT, G.
Publications
Furukawa TA, Watanabe N, Omori IM, Montori VM,
Guyatt GH. Association between unreported outcomes
and effect size estimates in Cochrane metaanalyses.
JAMA 2007 Feb 7; 297(5):468-70.
Straus S, Haynes B, Glasziou P, Dickersin K, Guyatt
G. Misunderstandings, misperceptions, and mistakes.
Evid Based Med 2007 Feb; 12(1):2-3.
Ferreira-Gonzalez I, Dos-Subira L, Guyatt GH.
Adjunctive antiarrhythmic drug therapy in patients
with implantable cardioverter defibrillators: a systematic
review. Eur Heart J 2007 Feb; 28(4):469-477.